New research from Boston Medical Center found that providing pragmatic support, specifically rapid access to antiretroviral therapy, pharmacotherapy for opioid use disorder, and strengths-based case management, improved treatment ...
Sep 1, 2023
0
1
In patients with HIV, a diabetes drug may have benefits beyond lowering blood sugar. A new study from researchers at Washington University School of Medicine in St. Louis suggests the drug may prevent cardiovascular problems ...
May 14, 2015
0
88
A phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was ...
Nov 4, 2022
0
33
A new combination treatment for HIV can strengthen a patient's immune response against the virus even after they stop taking traditional medications, according to a study published in the journal Science Immunology we co-led ...
Sep 30, 2021
0
1
Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, ...
May 30, 2023
0
44
A research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent immunosuppression (a low recent CD4 T-cell count [white blood cells that fight infection]) and prolonged ...
Mar 21, 2019
0
6
Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic and health-related ...
May 19, 2015
0
10
Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will be necessary to achieve a durable end to the HIV/AIDS pandemic, according to a new commentary ...
Oct 9, 2017
0
23
As 2020 draws closer, the deadline to end AIDS by 2030 looms large. The aim is to achieve the ambitious targets of "90-90-90." That is, 90% of people living with HIV knowing their status; 90% of all those with HIV on antiretroviral ...
Jun 10, 2019
0
1
In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study—a 10-nation, randomized clinical trial of adult outpatients—investigators concluded that there ...
Mar 17, 2016
0
5
